Summit Financial Wealth Advisors LLC Has $425,000 Holdings in Johnson & Johnson (JNJ)

Summit Financial Wealth Advisors LLC trimmed its position in shares of Johnson & Johnson (NYSE:JNJ) by 3.0% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,209 shares of the company’s stock after selling 98 shares during the quarter. Summit Financial Wealth Advisors LLC’s holdings in Johnson & Johnson were worth $425,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Numeric Investors LLC raised its position in shares of Johnson & Johnson by 846.6% in the 2nd quarter. Numeric Investors LLC now owns 412,700 shares of the company’s stock valued at $54,596,000 after purchasing an additional 369,100 shares during the last quarter. Brandywine Global Investment Management LLC raised its position in shares of Johnson & Johnson by 0.5% in the 2nd quarter. Brandywine Global Investment Management LLC now owns 2,441,264 shares of the company’s stock valued at $322,955,000 after purchasing an additional 13,020 shares during the last quarter. Zacks Investment Management raised its position in shares of Johnson & Johnson by 1.0% in the 2nd quarter. Zacks Investment Management now owns 650,976 shares of the company’s stock valued at $86,118,000 after purchasing an additional 6,445 shares during the last quarter. Voya Investment Management LLC raised its position in shares of Johnson & Johnson by 16.8% in the 2nd quarter. Voya Investment Management LLC now owns 4,046,617 shares of the company’s stock valued at $535,327,000 after purchasing an additional 582,023 shares during the last quarter. Finally, Mckinley Capital Management LLC Delaware raised its position in shares of Johnson & Johnson by 4.1% in the 2nd quarter. Mckinley Capital Management LLC Delaware now owns 424,969 shares of the company’s stock valued at $56,219,000 after purchasing an additional 16,631 shares during the last quarter. 65.90% of the stock is owned by institutional investors and hedge funds.

Several brokerages recently commented on JNJ. Piper Jaffray Companies reaffirmed a “hold” rating and issued a $120.00 price objective on shares of Johnson & Johnson in a research report on Wednesday, October 4th. Vetr downgraded shares of Johnson & Johnson from a “hold” rating to a “sell” rating and set a $130.49 price target on the stock. in a report on Monday, September 18th. Stifel Nicolaus increased their price target on shares of Johnson & Johnson from $140.00 to $142.00 and gave the stock a “hold” rating in a report on Wednesday, October 18th. UBS reiterated a “buy” rating and issued a $148.00 price target on shares of Johnson & Johnson in a report on Thursday, August 31st. Finally, Wells Fargo & Company upgraded shares of Johnson & Johnson from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $140.00 to $149.00 in a report on Monday, October 9th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Johnson & Johnson has a consensus rating of “Hold” and a consensus target price of $144.59.

Shares of Johnson & Johnson (NYSE:JNJ) traded up $0.58 during midday trading on Friday, hitting $140.59. 5,100,000 shares of the stock were exchanged, compared to its average volume of 4,754,087. The firm has a market cap of $377,697.84, a PE ratio of 19.69, a price-to-earnings-growth ratio of 2.86 and a beta of 0.80. Johnson & Johnson has a twelve month low of $110.76 and a twelve month high of $144.35. The company has a quick ratio of 1.02, a current ratio of 1.32 and a debt-to-equity ratio of 0.36.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 EPS for the quarter, topping analysts’ consensus estimates of $1.80 by $0.10. The business had revenue of $19.65 billion for the quarter, compared to analysts’ expectations of $19.29 billion. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The business’s revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the company earned $1.68 EPS. equities analysts forecast that Johnson & Johnson will post 7.28 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Tuesday, November 28th will be paid a dividend of $0.84 per share. The ex-dividend date is Monday, November 27th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.39%. Johnson & Johnson’s payout ratio is 58.33%.

TRADEMARK VIOLATION NOTICE: “Summit Financial Wealth Advisors LLC Has $425,000 Holdings in Johnson & Johnson (JNJ)” was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://sportsperspectives.com/2017/12/10/summit-financial-wealth-advisors-llc-has-425000-holdings-in-johnson-johnson-jnj.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply